EU-OPENSCREEN: A Future Pan-European Research Infrastructure for Chemical Biology; Sharing Samples, Expertise and Knowledge for the Discovery of Bioactive Small Molecules




Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening results, assay protocols, and chemical information.

[inlinead]

This interview was conducted at IQPC's 8th Compound Management & Integrity event in May 2011.

Have Your Say
Rate this feature and give us your feedback in the comments section below

Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening resu...
TO READ THE FULL STORY